(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 3.7% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Bruker's revenue in 2025 is $3,446,100,000.On average, 5 Wall Street analysts forecast BRKR's revenue for 2025 to be $532,656,714,252, with the lowest BRKR revenue forecast at $531,403,849,305, and the highest BRKR revenue forecast at $533,770,776,068. On average, 5 Wall Street analysts forecast BRKR's revenue for 2026 to be $558,033,139,173, with the lowest BRKR revenue forecast at $553,030,468,229, and the highest BRKR revenue forecast at $567,289,610,891.
In 2027, BRKR is forecast to generate $594,997,655,665 in revenue, with the lowest revenue forecast at $594,141,046,383 and the highest revenue forecast at $596,185,210,405.